Please login to the form below

Not currently logged in
Email:
Password:

New accounts: April

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period January 2005 to March 2005 inclusive.

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period January 2005 to March 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, e-mail websales@pmlive.com.

3M Health Care

Skin portfolio

Wound care

The Medical Multimedia Company

Abbott Laboratories

Kaletra

HIV

The Medical Multimedia Company

AstraZeneca (Global)

Zoladex

Prostate cancer

Tonic Life Communications

Baxter Healthcare

N/A

Haemodialysis

The Medical Multimedia Company

Boehringer Ingelheim

Mirapexin

Parkinson's disease

Lowe Fusion

GE Healthcare

New product

Nuclear medicine

Lowe Fusion

GE Healthcare

Steripet

Nuclear medicine

Lowe Fusion

GSK/Roche

Bonviva

Osteoporosis

Virgo Health PR

Janssen-Cilag

Tramacet

Pain

Lowe Fusion

Lilly/Boehringer Ingelheim

Yentreve nurse programme

Incontinence

Medicom Group

Merck KGaA

Erbitux

Metastatic colorectal cancer

Chandler Chicco Agency

Napp Pharmaceuticals

N/A

Pain

Axon Communications

National Health Service

Primary Care managers training programme

N/A

Medicom Group

Pfizer

Varenicline

Smoking cessation

Chandler Chicco Agency

PM Society

PRIME training programme

N/A

Helen Lawn & Associates

Replay Media

Corporate

N/A

Helen Lawn & Associates

Sankyo Pharmaceuticals

Olmetec

Cardiovascular

Kendle Healthcare

sanofi-aventis

Fasturtec

Hyperuricaemia

Discovery London

sanofi-aventis

Taxotere

Oncology

Discovery London

sanofi-aventis

Arava

Arthritis

Discovery London

sanofi-aventis

Xatral

Benign prostatic hyperplasia

Discovery London

Schering-Plough

Subutex

Opioid dependence

Discovery London

Schering-Plough

Viraferon-Peg

Hepatitis C

Discovery London

Servier

Procoralan

Cardiology

Shire Health London

Straken

Tostrex

Hypogonadism

Medicom Group

Yamanouchi

Flomax

Benign prostatic hyperplasia

Shire Health London

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics